10205164	207	Meili R	Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium.	The EMBO journal	1999	143
19026743	207	Zhao WQ	Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.	Biochimica et biophysica acta	2009	57
26367797	338	UK10K Consortium.	The UK10K project identifies rare variants in health and disease.	Nature	2015	168
14729357	348	Anderson DH	Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.	Experimental eye research	2004	88
24559670	348	Kanekiyo T	ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?	Neuron	2014	78
25988462	348	Jansen WJ	Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.	JAMA	2015	110
10978169	351	Walsh DM	The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.	Biochemistry	2000	118
16645451	351	Xie Z	The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels.	Anesthesiology	2006	75
17360908	351	Shankar GM	Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.	The Journal of neuroscience 	2007	461
18359102	351	Selkoe DJ	Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.	Behavioural brain research	2008	315
18548070	351	Kukar TL	Substrate-targeting gamma-secretase modulators.	Nature	2008	105
22017494	351	Rosen RF	Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.	Journal of neurochemistry	2012	37
25253695	351	Benilova I	The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.	The Journal of biological chemistry	2014	29
20413653	1020	Crews L	Molecular mechanisms of neurodegeneration in Alzheimer's disease.	Human molecular genetics	2010	107
10075921	1080	Meacham GC	The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis.	The EMBO journal	1999	107
19181854	1080	Rath A	Detergent binding explains anomalous SDS-PAGE migration of membrane proteins.	Proceedings of the National Academy of Sciences of the United States of America	2009	188
19944699	1080	Lewis HA	Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.	Journal of molecular biology	2010	51
22179788	1191	Narayan P	The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide.	Nature structural and molecular biology	2011	67
19011614	1401	Lu J	Structural recognition and functional activation of FcgammaR by innate pentraxins.	Nature	2008	70
27909051	1409	Mymrikov EV	The Chaperone Activity and Substrate Spectrum of Human Small Heat Shock Proteins.	The Journal of biological chemistry	2017	8
20843828	1410	Vos MJ	HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.	Human molecular genetics	2010	46
22683760	1410	Wettstein G	Small heat shock proteins and the cytoskeleton: an essential interplay for cell integrity?	The international journal of biochemistry and cell biology	2012	36
24942756	1437	Lutz ER	Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation.	Cancer immunology research	2014	70
26962052	1476	Ossenkoppele R	Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.	Brain 	2016	75
19203374	1509	Cullen V	Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.	Molecular brain	2009	70
19505575	1509	Chu Y	Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.	Neurobiology of disease	2009	88
15943797	1674	Sun Y	The small heat shock proteins and their role in human disease.	The FEBS journal	2005	70
12435727	1956	Andl CD	Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.	The Journal of biological chemistry	2003	95
15994331	1956	Clayton AH	Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.	The Journal of biological chemistry	2005	85
18458324	2056	Tong Z	Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.	Proceedings of the National Academy of Sciences of the United States of America	2008	55
24211234	2187	Davies AM	Structural determinants of unique properties of human IgG4-Fc.	Journal of molecular biology	2014	26
20020753	2244	Lacerda SH	Interaction of gold nanoparticles with common human blood proteins.	ACS nano	2010	71
11731781	2247	Zhang SC	In vitro differentiation of transplantable neural precursors from human embryonic stem cells.	Nature biotechnology	2001	391
19842915	2247	Solchaga LA	Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells.	Tissue engineering. Part A	2010	54
21494607	2247	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	129
9111868	2335	Naor D	CD44: structure, function, and association with the malignant process.	Advances in cancer research	1997	194
18424525	2335	Valle J	UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli.	Journal of bacteriology	2008	55
24059496	2475	Sarkar S	Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.	Biochemical Society transactions	2013	64
21408206	2521	Huang C	FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.	PLoS genetics	2011	65
26317470	2521	Patel A	A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation.	Cell	2015	139
9302293	3064	DiFiglia M	Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.	Science	1997	589
11406612	3064	Sittler A	Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease.	Human molecular genetics	2001	100
12747895	3064	Bates G	Huntingtin aggregation and toxicity in Huntington's disease.	Lancet	2003	106
14978262	3064	Lee WC	Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15340079	3064	Trushina E	Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.	Molecular and cellular biology	2004	141
16893904	3064	Ehrnhoefer DE	Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.	Human molecular genetics	2006	80
16980959	3064	Tam S	The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions.	Nature cell biology	2006	112
17118264	3064	Williams A	Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.	Current topics in developmental biology	2006	108
18756251	3064	Kaganovich D	Misfolded proteins partition between two distinct quality control compartments.	Nature	2008	286
19710014	3064	Aiken CT	Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.	The Journal of biological chemistry	2009	50
21571086	3064	Moreno-Gonzalez I	Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.	Seminars in cell and developmental biology	2011	42
22735540	3064	Pieri L	Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells.	Biophysical journal	2012	54
24706768	3064	Yu A	Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition.	Proceedings of the National Academy of Sciences of the United States of America	2014	35
25437566	3064	Brehme M	A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.	Cell reports	2014	68
27188817	3064	Bates GP	Huntington disease.	Nature reviews. Disease primers	2015	51
22693999	3135	Valleix S	Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.	The New England journal of medicine	2012	32
16076838	3297	Westerheide SD	Heat shock response modulators as therapeutic tools for diseases of protein conformation.	The Journal of biological chemistry	2005	137
19546513	3297	Calderwood SK	The shock of aging: molecular chaperones and the heat shock response in longevity and aging--a mini-review.	Gerontology	2009	81
21451522	3297	Alavez S	Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan.	Nature	2011	91
14740253	3308	Wegele H	Hsp70 and Hsp90--a relay team for protein folding.	Reviews of physiology, biochemistry and pharmacology	2004	140
19393652	3308	Broadley SA	The role of molecular chaperones in human misfolding diseases.	FEBS letters	2009	59
22449631	3308	Garrido C	The small heat shock proteins family: the long forgotten chaperones.	The international journal of biochemistry and cell biology	2012	47
26300264	3308	Gao X	Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.	Molecular cell	2015	42
26865365	3308	Radons J	The human HSP70 family of chaperones: where do we stand?	Cell stress and chaperones	2016	22
11772336	3320	Maloney A	HSP90 as a new therapeutic target for cancer therapy: the story unfolds.	Expert opinion on biological therapy	2002	91
23791384	3337	Park SH	PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone.	Cell	2013	100
2195544	3375	Westermark P	Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.	Proceedings of the National Academy of Sciences of the United States of America	1990	157
18442979	3375	Apostolidou M	Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding.	The Journal of biological chemistry	2008	67
19208933	3375	Abedini A	A role for helical intermediates in amyloid formation by natively unfolded polypeptides?	Physical biology	2009	57
19244249	3375	Patil SM	Dynamic alpha-helix structure of micelle-bound human amylin.	The Journal of biological chemistry	2009	51
19346479	3375	Shim SH	Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution.	Proceedings of the National Academy of Sciences of the United States of America	2009	93
21723249	3375	Nanga RP	Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment.	Biochimica et biophysica acta	2011	46
21818468	3375	DeToma AS	Misfolded proteins in Alzheimer's disease and type II diabetes.	Chemical Society reviews	2012	53
21916515	3375	Wang L	2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure.	Journal of the American Chemical Society	2011	36
21942864	3375	Brender JR	Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.	Accounts of chemical research	2012	67
23611538	3375	Palhano FL	Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils.	Journal of the American Chemical Society	2013	41
24218609	3375	Buchanan LE	Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet.	Proceedings of the National Academy of Sciences of the United States of America	2013	39
25515893	3375	Young LM	Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry.	Nature chemistry	2015	27
3086451	3383	Dustin ML	Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).	Journal of immunology	1986	369
3525675	3383	Rothlein R	A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.	Journal of immunology	1986	233
9347951	3383	Newbold C	Receptor-specific adhesion and clinical disease in Plasmodium falciparum.	The American journal of tropical medicine and hygiene	1997	118
16429128	3383	Millán J	Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains.	Nature cell biology	2006	107
24219905	3458	Zimmermann JA	Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.	Cytotherapy	2014	31
21408027	3569	Bao B	Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.	PloS one	2011	73
15292279	3630	Hull RL	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	125
15564314	3630	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	101
20739751	3949	Rashid ST	Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.	The Journal of clinical investigation	2010	170
9039909	4069	Booth DR	Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.	Nature	1997	175
15361882	4069	Fernandez-Escamilla AM	Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.	Nature biotechnology	2004	327
20930119	4072	Stott SL	Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.	Proceedings of the National Academy of Sciences of the United States of America	2010	353
16807328	4137	Dickey CA	Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.	The Journal of neuroscience 	2006	79
17683088	4137	Goris A	Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.	Annals of neurology	2007	69
18199773	4137	Mocanu MM	The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.	The Journal of neuroscience 	2008	75
18798283	4137	LaPointe NE	The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.	Journal of neuroscience research	2009	86
21427723	4137	Cohen TJ	The acetylation of tau inhibits its function and promotes pathological tau aggregation.	Nature communications	2011	110
22556362	4137	Coppola G	Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.	Human molecular genetics	2012	57
23684085	4137	Spillantini MG	Tau pathology and neurodegeneration.	The Lancet. Neurology	2013	144
25393609	4137	Sokolow S	Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.	Journal of neurochemistry	2015	20
22113611	4287	Koch P	Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.	Nature	2011	78
20522742	5265	Hidvegi T	An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.	Science	2010	169
15313629	5621	Linding R	A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins.	Journal of molecular biology	2004	82
19789378	5621	Aguzzi A	Prions: protein aggregation and infectious diseases.	Physiological reviews	2009	123
22057275	5621	Saman S	Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.	The Journal of biological chemistry	2012	182
26324905	5621	Prusiner SB	Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2015	81
26791950	5621	Minikel EV	Quantifying prion disease penetrance using large population control cohorts.	Science translational medicine	2016	32
17553989	5663	Klunk WE	Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.	The Journal of neuroscience 	2007	117
17962197	5663	Page RM	Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.	The Journal of biological chemistry	2008	54
18300294	5663	Tomiyama T	A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.	Annals of neurology	2008	111
25307057	5663	Choi SH	A three-dimensional human neural cell culture model of Alzheimer's disease.	Nature	2014	138
26481686	5663	Szaruga M	Qualitative changes in human γ-secretase underlie familial Alzheimer's disease.	The Journal of experimental medicine	2015	20
9546347	6620	Baba M	Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.	The American journal of pathology	1998	271
10391881	6622	Wood SJ	alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.	The Journal of biological chemistry	1999	124
11152691	6622	Uversky VN	Evidence for a partially folded intermediate in alpha-synuclein fibril formation.	The Journal of biological chemistry	2001	195
11553618	6622	Uversky VN	Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.	The Journal of biological chemistry	2001	183
11560511	6622	Li J	Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.	Biochemistry	2001	109
11572944	6622	Masliah E	beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	117
12084935	6622	Lee MK	Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --&amp;gt; Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	157
12122208	6622	Lo Bianco C	alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2002	113
12177198	6622	Sherer TB	An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.	The Journal of neuroscience 	2002	123
12217698	6622	Hoyer W	Dependence of alpha-synuclein aggregate morphology on solution conditions.	Journal of molecular biology	2002	98
15845543	6622	Shin Y	The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways.	The Journal of biological chemistry	2005	85
16507759	6622	El-Agnaf OM	Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.	FASEB journal 	2006	140
17088319	6622	Marsh JA	Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.	Protein science 	2006	177
17254549	6622	Hoozemans JJ	Activation of the unfolded protein response in Parkinson's disease.	Biochemical and biophysical research communications	2007	95
18511942	6622	Ehrnhoefer DE	EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.	Nature structural and molecular biology	2008	220
18704197	6622	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
18769546	6622	Tsigelny IF	Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.	PloS one	2008	77
19686384	6622	Danzer KM	Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.	Journal of neurochemistry	2009	76
19745811	6622	Karpinar DP	Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.	The EMBO journal	2009	101
19892735	6622	Luk KC	Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	209
20071342	6622	Lee HJ	Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.	The Journal of biological chemistry	2010	188
20203178	6622	Paleologou KE	Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.	The Journal of neuroscience 	2010	71
20696318	6622	Oueslati A	Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.	Progress in brain research	2010	72
21613474	6622	Waxman EA	Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.	The Journal of neuroscience 	2011	44
21700325	6622	Mazzulli JR	Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.	Cell	2011	241
21766334	6622	Shannon KM	Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.	Movement disorders 	2012	60
22737239	6622	Angot E	Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.	PloS one	2012	50
22744791	6622	Ebrahimi-Fakhari D	Protein degradation pathways in Parkinson's disease: curse or blessing.	Acta neuropathologica	2012	36
25580161	6622	Kim WS	Alpha-synuclein biology in Lewy body diseases.	Alzheimer's research and therapy	2014	30
25676491	6622	Sengupta U	Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.	Biological psychiatry	2015	25
26341711	6622	Petrucci S	Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models.	Parkinsonism and related disorders	2016	15
26446103	6622	Uchihara T	Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.	Acta neuropathologica	2016	22
26564470	6622	Deas E	Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.	Antioxidants and redox signaling	2016	23
26808899	6622	Theillet FX	Structural disorder of monomeric α-synuclein persists in mammalian cells.	Nature	2016	54
15326189	6647	Arnesano F	The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status.	The Journal of biological chemistry	2004	75
15758154	6647	Vijayvergiya C	Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.	The Journal of neuroscience 	2005	70
17592131	6647	Banci L	Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2007	78
18282652	6647	Turner BJ	Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.	Progress in neurobiology	2008	152
18666828	6647	Wang Q	Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.	PLoS biology	2008	55
19271992	6647	Chattopadhyay M	Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.	Antioxidants and redox signaling	2009	45
19299510	6647	Wilcox KC	Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis.	The Journal of biological chemistry	2009	48
19483195	6647	Prudencio M	Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.	Human molecular genetics	2009	62
19903735	6647	Walker AK	Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.	Brain 	2010	45
20111867	6647	Kerman A	Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.	Acta neuropathologica	2010	53
20644736	6647	Forsberg K	Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.	PloS one	2010	89
22431618	6647	Brotherton TE	Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22967507	6647	Weisberg SJ	Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2012	37
9457080	7040	Johnstone B	In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells.	Experimental cell research	1998	414
22715097	7157	Ano Bom AP	Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.	The Journal of biological chemistry	2012	43
26748848	7157	Soragni A	A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.	Cancer cell	2016	24
15182180	7276	Hurshman AR	Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.	Biochemistry	2004	86
22645360	7276	Bulawa CE	Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.	Proceedings of the National Academy of Sciences of the United States of America	2012	108
24912163	7431	Wang S	Characterization and development of photoactivatable fluorescent proteins for single-molecule-based superresolution imaging.	Proceedings of the National Academy of Sciences of the United States of America	2014	70
20018885	8878	Pankiv S	Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.	The Journal of biological chemistry	2010	58
19910924	10013	Fiesel FC	Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6.	The EMBO journal	2010	90
23962722	10013	Cook C	Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.	Human molecular genetics	2014	42
21231916	10049	Hageman J	The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.	The Biochemical journal	2011	48
22334415	10049	Harms MB	Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.	Annals of neurology	2012	39
23178947	10133	Korac J	Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates.	Journal of cell science	2013	64
23673820	10133	Blokhuis AM	Protein aggregation in amyotrophic lateral sclerosis.	Acta neuropathologica	2013	61
21478269	10273	Li D	Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.	Molecular cancer research 	2011	67
23737532	10808	Mattoo RU	Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates.	The Journal of biological chemistry	2013	46
15502874	11315	Shendelman S	DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.	PLoS biology	2004	140
15952880	11315	Cookson MR	The biochemistry of Parkinson's disease.	Annual review of biochemistry	2005	172
16227205	11315	Zhou W	DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.	The Journal of biological chemistry	2005	98
21245577	23336	Hansen C	α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.	The Journal of clinical investigation	2011	224
23744071	23336	Prots I	α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.	The Journal of biological chemistry	2013	28
24728187	23336	Fares MB	The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.	Human molecular genetics	2014	29
25416158	23336	Harischandra DS	α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.	Toxicological sciences 	2015	22
26179554	23336	Keshavarzian A	Colonic bacterial composition in Parkinson's disease.	Movement disorders 	2015	42
18434538	23435	Johnson BS	A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2008	154
19383787	23435	Zhang YJ	Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	168
19465477	23435	Johnson BS	TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.	The Journal of biological chemistry	2009	192
19515851	23435	Nonaka T	Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.	Human molecular genetics	2009	86
19833869	23435	Wegorzewska I	TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2009	196
19959528	23435	Kabashi E	Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.	Human molecular genetics	2010	128
20154090	23435	Hanson KA	Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS).	The Journal of biological chemistry	2010	57
20702714	23435	Xu YF	Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.	The Journal of neuroscience 	2010	140
21209826	23435	Yang C	The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism.	PloS one	2010	49
21355045	23435	Zhang T	TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling.	Human molecular genetics	2011	37
21454603	23435	Furukawa Y	A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions.	The Journal of biological chemistry	2011	63
21454607	23435	Pesiridis GS	A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport.	The Journal of biological chemistry	2011	45
21541367	23435	Sun Z	Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.	PLoS biology	2011	124
21847013	23435	Gitler AD	RNA-binding proteins with prion-like domains in ALS and FTLD-U.	Prion	2011	47
22028219	23435	Jucker M	Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.	Annals of neurology	2011	151
22029574	23435	Xu YF	Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.	Molecular neurodegeneration	2011	47
23629963	23435	Li YR	Stress granules as crucibles of ALS pathogenesis.	The Journal of cell biology	2013	184
23831027	23435	Nonaka T	Prion-like properties of pathological TDP-43 aggregates from diseased brains.	Cell reports	2013	72
23891805	23435	Burkhardt MF	A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.	Molecular and cellular neurosciences	2013	55
23900071	23435	Janssens J	Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.	Human molecular genetics	2013	33
26669444	23435	Lokireddy S	cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
27015757	23435	Ratti A	Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.	Journal of neurochemistry	2016	25
17287498	23621	Xie Z	The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation.	The Journal of neuroscience 	2007	77
19006075	23621	Xie Z	The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo.	Annals of neurology	2008	93
19815015	23621	Hampel H	Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.	Experimental neurology	2010	45
22518844	23636	Liu XD	Transient aggregation of ubiquitinated proteins is a cytosolic unfolded protein response to inflammation and endoplasmic reticulum stress.	The Journal of biological chemistry	2012	34
22689910	23636	Schaeffer V	Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.	Brain 	2012	64
18006506	26353	Carra S	HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy.	The Journal of biological chemistry	2008	91
26576562	51115	Lewis J	Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.	Acta neuropathologica	2016	18
24942732	54205	Luth ES	Soluble, prefibrillar α-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction.	The Journal of biological chemistry	2014	29
16437584	120892	Giasson BI	Biochemical and pathological characterization of Lrrk2.	Annals of neurology	2006	68
23423380	203228	Reddy K	The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.	The Journal of biological chemistry	2013	89
25120191	203228	May S	C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.	Acta neuropathologica	2014	60
25173361	203228	Zhang YJ	Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress.	Acta neuropathologica	2014	61
25521377	203228	Wen X	Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death.	Neuron	2014	77
25575510	203228	Tao Z	Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity.	Human molecular genetics	2015	34
27097283	203228	Dafinca R	C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.	Stem cells	2016	20
